103 related articles for article (PubMed ID: 21178581)
1. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
Lindboe CF; Løvdal L
Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
[TBL] [Abstract][Full Text] [Related]
2. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
[TBL] [Abstract][Full Text] [Related]
4. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
[TBL] [Abstract][Full Text] [Related]
7. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelioma of Pinkus is a true basal cell carcinoma developing in association with a newly identified tumour-specific type of epidermal hyperplasia.
Sellheyer K; Nelson P; Kutzner H
Br J Dermatol; 2012 Jan; 166(1):88-97. PubMed ID: 21910710
[TBL] [Abstract][Full Text] [Related]
9. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
Tuttle MS; Rosenberg AS; Winfield HL; Somach SC
Am J Dermatopathol; 2009 Aug; 31(6):557-60. PubMed ID: 19590419
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
Goette DK; Helwig EB
Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
[TBL] [Abstract][Full Text] [Related]
11. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
Han KH; Huh CH; Cho KH
Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
[TBL] [Abstract][Full Text] [Related]
12. Follicular induction and CK20+ Merkel cells overlying cutaneous focal mucinosis.
Chairatchaneeboon M; Elenitsas R; Nguyen JV
J Cutan Pathol; 2019 Mar; 46(3):195-198. PubMed ID: 30552701
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
16. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
17. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
18. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
Rossen K; Hou-Jensen K; Werdelin O
Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]